cGMP Dependent Kinase Inhibitor Peptide contains residues designed to disrupt substrate docking within cGMP-dependent protein kinase pathways. The sequence includes motifs influencing charge distribution, helix formation, and kinase interaction. Researchers apply it to study regulatory loops and catalytic specificity. Its defined structure supports enzymatic and mechanistic analyses.
CAT No: R0846
CAS No:82801-73-8
Synonyms/Alias:82801-73-8;Arg-Lys-Arg-Ala-Arg-Lys-Glu;PKG inhibitor peptide;cGMP Dependent Kinase Inhibitor Peptide;Arg-7-glu;RKRARKE;Arginyl-lysyl-arginyl-alanyl-arginyl-lysyl-glutamic acid;(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]pentanedioic acid;L-Glutamic acid, N-(N2-(N2-(N-(N2-(N2-L-arginyl-L-lysyl)-L-arginyl)-L-alanyl)-L-arginyl)-L-lysyl)-;Alg-Lys-Arg-Ala-Arg-Lys-Glu;SCHEMBL7447958;HDA80173;HY-P1292;AKOS024456827;[Ala32]-Histone H2B (29-35);DA-77486;MS-31758;CS-0029296;G12289;(S)-2-((6S,9S,12S,15S,18S,21S)-1,6-Diamino-9,21-bis(4-aminobutyl)-12,18-bis(3-guanidinopropyl)-1-imino-15-methyl-7,10,13,16,19-pentaoxo-2,8,11,14,17,20-hexaazadocosanamido)pentanedioic acid;
1. Cationic cell-penetrating peptides are potent furin inhibitors
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.